Science & Technology
SBIR Phase I: The TPMAL Platform for Targeted Delivery of Photodynamic Therapy and Chemotherapy to Peritoneal Metastasis
National Science Foundation
Opportunity #: 2507639
Award Ceiling
$305K
Award Floor
$305K
Close Date
May 31, 2026
77 days leftTotal Funding
$305K
Expected Awards
1
Posted Date
Jun 2, 2025
Cost Sharing Required
No
Grants.gov ID
sbir-2507639
Description
SBIR Phase Phase I award: "SBIR Phase I: The TPMAL Platform for Targeted Delivery of Photodynamic Therapy and Chemotherapy to Peritoneal Metastasis" awarded to Glow Therapeutics Inc. in Washington, District of Columbia. Funded by National Science Foundation. Award amount: $305,000. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.